|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CURRENT ASSETS: | ||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||
| Accounts receivable — net of allowance for doubtful accounts $17 at June 30, 2018 and $0 at December 31, 2017 | ||||||||||||||||||
| Unbilled revenue | ||||||||||||||||||
| Inventories — net (Note 5) | ||||||||||||||||||
| Deferred costs | ||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||
| Assets held for sale | ||||||||||||||||||
| Total current assets | ||||||||||||||||||
| Property, plant and equipment — net (Note 6) | ||||||||||||||||||
| Intangible assets — net (Note 6) | ||||||||||||||||||
| Goodwill | ||||||||||||||||||
| Deferred income taxes (Note 14) | ||||||||||||||||||
| Other assets | ||||||||||||||||||
| Total Assets | ||||||||||||||||||
| CURRENT LIABILITIES: | ||||||||||||||||||
| Working capital revolving line of credit (Note 8) | ||||||||||||||||||
| Accounts payable | ||||||||||||||||||
| Accrued expenses (Note 9) | ||||||||||||||||||
| Accrued compensation | ||||||||||||||||||
| Deferred revenue | ||||||||||||||||||
| Deferred income taxes (Note 14) | ||||||||||||||||||
| Customer deposits | ||||||||||||||||||
| Other current liabilities | ||||||||||||||||||
| Liabilities held for sale | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Deferred revenue, less current portion | ||||||||||||||||||
| Long-term debt, less current portion (Note 9) | ||||||||||||||||||
| Deferred income taxes (Note 13) | ||||||||||||||||||
| Other long-term liability | ||||||||||||||||||
| Total Liabilities | ||||||||||||||||||
| SHAREHOLDERS’ DEFICIENCY: | ||||||||||||||||||
| Voting common shares, no par value — Unlimited shares authorized; 23,853,884 shares issued and outstanding as of June 30, 2018 and December31, 2017 | ||||||||||||||||||
| Voting Common Shares-No Par, Unlimited Shares Authorized | ||||||||||||||||||
| Total voting common shares, no par value — Unlimited shares authorized; 23,853,884 shares issued and outstanding as of June 30, 2018 and December31, 2017 | ||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| Total Shareholders’ Deficiency | ||||||||||||||||||
| Total Liabilities and Shareholders’ Deficiency | ||||||||||||||||||
Loading...